• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Oscar Health Inc. (Amendment)

    2/1/24 7:11:20 PM ET
    $OSCR
    Medical Specialities
    Health Care
    Get the next $OSCR alert in real time by email
    SC 13G/A 1 schedule13ga.htm AMENDMENT NO. 1
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C.  20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.  1 )*



    Oscar Health, Inc.
    (Name of Issuer)
     
    Class A Common Stock, par value $0.00001 per share
    (Title of Class of Securities)
     
    687793109
    (CUSIP Number)
     
    December 31, 2023
    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐
    Rule 13d-1(b)
    ☐
    Rule 13d-1(c)
    ☒
    Rule 13d-1(d)


    *  The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     

    1
    NAME OF REPORTING PERSONS.
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
    CapitalG 2015 LP
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a) ☐
    (b) ☒
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
    5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    0
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    0.0%
    12
    TYPE OF REPORTING PERSON (See Instructions)
    PN


    1
    NAME OF REPORTING PERSONS.
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
    CapitalG 2015 GP LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a) ☐
    (b) ☒
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
    5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    0
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    0.0%
    12
    TYPE OF REPORTING PERSON (See Instructions)
    OO


    1
    NAME OF REPORTING PERSONS.
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
    CapitalG LP
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a) ☐
    (b) ☒
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
    5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    0
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    0.0%
    12
    TYPE OF REPORTING PERSON (See Instructions)
    PN


    1
    NAME OF REPORTING PERSONS.
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
    CapitalG GP LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a) ☐
    (b) ☒
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
    5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    0
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    0.0%
    12
    TYPE OF REPORTING PERSON (See Instructions)
    OO


    13
    NAME OF REPORTING PERSONS.
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
    GV 2014, L.P.
    14
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a) ☐
    (b) ☒
    15
    SEC USE ONLY
     
    16
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
    17
    SOLE VOTING POWER
    481,988
    18
    SHARED VOTING POWER
    0
    19
    SOLE DISPOSITIVE POWER
    481,988
    20
    SHARED DISPOSITIVE POWER
    0
    21
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    481,988
    22
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐
    23
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    0.3%
    24
    TYPE OF REPORTING PERSON (See Instructions)
    PN


    25
    NAME OF REPORTING PERSONS.
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
    GV 2014 GP, L.L.C.
    26
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a) ☐
    (b) ☒
    27
    SEC USE ONLY
     
    28
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
    29
    SOLE VOTING POWER
    481,988
    30
    SHARED VOTING POWER
    0
    31
    SOLE DISPOSITIVE POWER
    481,988
    32
    SHARED DISPOSITIVE POWER
    0
    33
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    481,988
    34
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐
    35
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    0.3%
    36
    TYPE OF REPORTING PERSON (See Instructions)
    OO


    1
    NAME OF REPORTING PERSONS.
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
    Verily Life Sciences LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a) ☐
    (b) ☒
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
    5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    0
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    0.0%
    12
    TYPE OF REPORTING PERSON (See Instructions)
    OO


    1
    NAME OF REPORTING PERSONS.
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
    Alphabet Holdings LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a) ☐
    (b) ☒
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
    5
    SOLE VOTING POWER
    1,629,087
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    1,629,087
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,629,087
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    0.9%
    12
    TYPE OF REPORTING PERSON (See Instructions)
    OO


    1
    NAME OF REPORTING PERSONS.
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
    Alphabet Inc.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a) ☐
    (b) ☒
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
    5
    SOLE VOTING POWER
    1,629,087
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    1,629,087
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,629,087
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    0.9%
    12
    TYPE OF REPORTING PERSON (See Instructions)
    CO



    Item 1. (a)             Name of Issuer

    Oscar Health, Inc.


    (b)
    Address of Issuer’s Principal Executive Offices

    75 Varick Street, 5th Floor
    New York, NY 10013

    Item 2. (a) Name of Person Filing

    This statement is filed by the following entities (collectively, referred to as the “Reporting Persons”):


    •
    CapitalG 2015 LP, a Delaware limited partnership;

    •
    CapitalG 2015 GP LLC, a Delaware limited liability company;

    •
    CapitalG LP, a Delaware limited partnership;

    •
    CapitalG GP LLC, a Delaware limited liability company;

    •
    GV 2014, L.P., a Delaware limited partnership;

    •
    GV 2014 GP, L.L.C., a Delaware limited liability company;

    •
    Verily Life Sciences LLC, a Delaware limited liability company;

    •
    Alphabet Holdings LLC, a Delaware limited liability company; and

    •
    Alphabet Inc., a Delaware corporation.

    CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, may be deemed to have sole voting and dispositive power with respect to the shares held by CapitalG 2015 LP.

    CapitalG GP LLC, the general partner of CapitalG LP, may be deemed to have sole voting and dispositive power with respect to the shares held by CapitalG LP.

    GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., may be deemed to have sole voting and dispositive power with respect to the shares held by GV 2014, L.P.

    Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, CapitalG GP LLC, and GV 2014 GP, L.L.C., may be deemed to have sole voting and dispositive power with respect to the shares held by CapitalG 2015 LP, CapitalG LP and GV 2014, L.P.  Alphabet Holdings LLC disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.

    XXVI Holdings Inc., the managing member of Alphabet Holdings LLC and Verily Life Sciences LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held by CapitalG 2015 LP, CapitalG LP, GV 2014, L.P. and Verily Life Sciences LLC.  Each of XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.


    (b)
    Address of Principal Business Office or, if none, Residence


    The address of the principal business office for each of the Reporting Persons is:

    1600 Amphitheatre Parkway
    Mountain View, CA 94043


    (c)
    Citizenship

    See Row 4 of cover page for each Reporting Person.


    (d)
    Title of Class of Securities

    Class A Common Stock, par value $0.00001 per share.

    (e)            CUSIP Number

    687793109

    Item 3.
    If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

    Not applicable.

    Item 4.
    Ownership.


    (a)
    Amount beneficially owned:

    See Row 9 of cover page for each Reporting Person.


    (b)
    Percent of class:

    See Row 11 of cover page for each Reporting Person.


    (c)
    Number of shares as to which the person has:

    (i) Sole power to vote or to direct the vote:

    See Row 5 of cover page for each Reporting Person.

    (ii) Shared power to vote or to direct the vote:

    See Row 6 of cover page for each Reporting Person.

    (iii) Sole power to dispose or to direct the disposition of:

    See Row 7 of cover page for each Reporting Person.

    (iv) Shared power to dispose or to direct the disposition of:

    See Row 8 of cover page for each Reporting Person.


    Item 5.
    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof certain of the Reporting Persons have ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ý.

    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

    Not applicable.

    Item 8.
    Identification and Classification of Members of the Group.

    Not applicable.

    Item 9.
    Notice of Dissolution of Group.

    Not applicable.

    Item 10.
    Certification.

    Not applicable.






    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 1, 2024

     
    CAPITALG 2015 LP
     
    By: CapitalG 2015 GP LLC
           its General Partner

    By:             /s/ Bryan S. Keighery                                    
    Name:   Bryan S. Keighery
    Title:       Attorney-in-fact


    CAPITALG 2015 GP LLC

    By:             /s/ Bryan S. Keighery                                    
    Name:   Bryan S. Keighery
    Title:       Attorney-in-fact

     
    CAPITALG LP
     
    By: CapitalG GP LLC
           its General Partner

    By:             /s/ Bryan S. Keighery                                    
    Name:   Bryan S. Keighery
    Title:       Attorney-in-fact


    CAPITALG GP LLC

    By:             /s/ Bryan S. Keighery                                    
    Name:   Bryan S. Keighery
    Title:       Attorney-in-fact


    GV 2014, L.P.
     
    By: GV 2014 GP, L.L.C.
           its General Partner

    By:             /s/ Bryan S. Keighery                                    
    Name:   Bryan S. Keighery
    Title:       Attorney-in-fact


    GV 2014 GP, L.L.C.

    By:             /s/ Bryan S. Keighery                                    
    Name:   Bryan S. Keighery
    Title:       Attorney-in-fact

     
    VERILY LIFE SCIENCES LLC

    By:             /s/ Bryan S. Keighery                                    
    Name:   Bryan S. Keighery
    Title:       Attorney-in-fact


    ALPHABET HOLDINGS LLC


    By:             /s/ Bryan S. Keighery                                    
    Name:   Bryan S. Keighery
    Title:       Attorney-in-fact


    ALPHABET INC.


    By:             /s/ Bryan S. Keighery                                    
    Name:   Bryan S. Keighery
    Title:       Attorney-in-fact




    Get the next $OSCR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OSCR

    DatePrice TargetRatingAnalyst
    2/12/2026$18.00Mkt Perform → Outperform
    Raymond James
    1/9/2026$17.00Sell → Neutral
    UBS
    1/5/2026$18.00Underweight → Equal Weight
    Barclays
    12/11/2025$17.00Equal-Weight
    Stephens
    11/26/2025$25.00Neutral → Overweight
    Piper Sandler
    10/14/2025$17.00Neutral
    Goldman
    7/25/2025$14.00Outperform → Neutral
    Robert W. Baird
    7/15/2025$11.00Neutral → Sell
    UBS
    More analyst ratings

    $OSCR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Boyd Jeffery H

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    1/12/26 4:21:59 PM ET
    $OSCR
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Gassen William

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    1/12/26 4:21:37 PM ET
    $OSCR
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Plouffe David

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    1/12/26 4:18:52 PM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Thrive Partners Vii Growth Gp, Llc bought $3,185,681 worth of shares (188,395 units at $16.91) (SEC Form 4)

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    11/22/24 4:33:02 PM ET
    $OSCR
    Medical Specialities
    Health Care

    Co-Founder and Vice Chairman Kushner Joshua bought $3,185,681 worth of shares (188,395 units at $16.91) (SEC Form 4)

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    11/22/24 4:29:47 PM ET
    $OSCR
    Medical Specialities
    Health Care

    Director Thrive Partners Vii Growth Gp, Llc bought $5,444,343 worth of shares (344,522 units at $15.80) (SEC Form 4)

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    11/18/24 5:02:12 PM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oscar Health Announces Financial Results for Fourth Quarter and Full-Year 2025

    Achieves Record Membership of ~3.4 Million and Provides Full-Year 2026 Outlook Including More Than $18 Billion in Revenue Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the fourth quarter and full year ended December 31, 2025. "2025 was a reset year for the individual market, and we took decisive actions to return to profitability in 2026," said Mark Bertolini, CEO of Oscar Health. "Our new suite of affordable products, agentic AI features, and exceptional member experience drove record-high membership – positioning us to achieve significantly improved financial performance in 2026. Oscar's growth demonstrates consumers vote where the

    2/10/26 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health, Inc. 2025 Fourth Quarter and Full Year Earnings Conference Call

    Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2025 financial results before the market opens on Tuesday, February 10, 2026. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following February 10, 2026 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack techno

    1/13/26 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Healthcare AI Exits Pilot Phase, Enters Production Deployment

    VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – Healthcare organizations are setting the pace for enterprise AI adoption as operational automation moves from experimentation to production scale across hospital systems[1]. The shift reflects a fundamental change in how healthcare leaders view AI technology, with deployment projected to expand the global healthcare AI market from $17.2 billion in 2025 to $77.2 billion by 2035[2]. Five publicly traded companies are positioned at the intersection of this operational transformation, delivering infrastructure that turns AI capabilities into measurable workflow improvements and financial returns

    12/12/25 9:59:27 AM ET
    $CERT
    $CTSH
    $DOCS
    Computer Software: Prepackaged Software
    Technology
    EDP Services
    Medical Specialities

    $OSCR
    SEC Filings

    View All

    SEC Form S-8 filed by Oscar Health Inc.

    S-8 - Oscar Health, Inc. (0001568651) (Filer)

    2/13/26 4:41:35 PM ET
    $OSCR
    Medical Specialities
    Health Care

    SEC Form 10-K filed by Oscar Health Inc.

    10-K - Oscar Health, Inc. (0001568651) (Filer)

    2/13/26 4:27:33 PM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Oscar Health, Inc. (0001568651) (Filer)

    2/10/26 6:25:47 AM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oscar Health upgraded by Raymond James with a new price target

    Raymond James upgraded Oscar Health from Mkt Perform to Outperform and set a new price target of $18.00

    2/12/26 7:19:33 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health upgraded by UBS with a new price target

    UBS upgraded Oscar Health from Sell to Neutral and set a new price target of $17.00

    1/9/26 8:33:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health upgraded by Barclays with a new price target

    Barclays upgraded Oscar Health from Underweight to Equal Weight and set a new price target of $18.00

    1/5/26 8:36:06 AM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Oscar Health Inc.

    SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)

    11/14/24 4:07:27 PM ET
    $OSCR
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Oscar Health Inc.

    SC 13G - Oscar Health, Inc. (0001568651) (Subject)

    11/14/24 1:28:35 PM ET
    $OSCR
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Oscar Health Inc.

    SC 13D/A - Oscar Health, Inc. (0001568651) (Subject)

    11/13/24 9:24:55 PM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Financials

    Live finance-specific insights

    View All

    Oscar Health Announces Financial Results for Fourth Quarter and Full-Year 2025

    Achieves Record Membership of ~3.4 Million and Provides Full-Year 2026 Outlook Including More Than $18 Billion in Revenue Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the fourth quarter and full year ended December 31, 2025. "2025 was a reset year for the individual market, and we took decisive actions to return to profitability in 2026," said Mark Bertolini, CEO of Oscar Health. "Our new suite of affordable products, agentic AI features, and exceptional member experience drove record-high membership – positioning us to achieve significantly improved financial performance in 2026. Oscar's growth demonstrates consumers vote where the

    2/10/26 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health, Inc. 2025 Fourth Quarter and Full Year Earnings Conference Call

    Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2025 financial results before the market opens on Tuesday, February 10, 2026. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following February 10, 2026 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack techno

    1/13/26 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health Announces Financial Results for Third Quarter 2025 and Reaffirms 2025 Guidance

    Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the third quarter ended September 30, 2025, and reaffirmed its full year 2025 outlook, across all metrics, as provided in its preliminary financial results press release dated July 22, 2025. "The individual market is the only source of affordable health coverage for 22 million people who power our economy," said Mark Bertolini, CEO of Oscar Health. "Our market serves the small business, service, and farming sectors, and can meet the healthcare needs of 100 million more working people. Oscar is shaping the future of individual healthcare with affordable, innovative plans and a superior member

    11/6/25 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Leadership Updates

    Live Leadership Updates

    View All

    Oscar Health, Inc. Announces Inducement Grants under Section 303A.08 of the NYSE Listed Company Manual

    Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar's Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar's common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates. The awards generally vest quarterly over a one-year period following their vesting commencement date, subject to continued employment. The awards were granted under Oscar's 2022 Employment Inducement Award Plan as employment inducement awards pursuant to the New York

    1/26/24 8:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health Welcomes Two Healthcare Veterans to its Executive Leadership Team

    Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built around a full stack technology platform, today announced the appointment of two seasoned healthcare executives to round out its leadership bench and further propel its vision to refactor healthcare. Kerry Sain has joined the company as the Executive Vice President of +Oscar, effective August 14, 2023, and Steven Kelmar will join as Executive Vice President and Chief of Staff to the CEO, effective September 21, 2023. In her role, Sain oversees the go-to-market strategy for the +Oscar business and will work closely with Mario Schlosser, President of Technology and Chief Technology Officer, to continue externa

    9/6/23 8:30:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health, Inc. Appoints Dr. Sean Martin, MD as New Chief Medical Officer

    Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, today announced that Dr. Sean Martin, MD has been appointed to serve as the company's new Chief Medical Officer, effective immediately. Dr. Martin joined Oscar in 2016 and during his tenure has provided clinical leadership across a number of core clinical functions, including enterprise affordability, medical management, market performance, population health, and behavioral health. In his new role, he will be responsible for implementing Oscar's clinical capabilities and enhancing the quality of care and outcomes for its members. "Dr. Martin is an avid champion of the us

    3/15/23 8:30:00 AM ET
    $OSCR
    Medical Specialities
    Health Care